A socially oriented non-financial development institution and a major organizer of international conventions, congress, exhibitions, business, social and sporting, public, and cultural events.

The Roscongress Foundation – a socially oriented non-financial development institution and a major organizer of international conventions, congress, exhibitions, business, social and sporting, public, and cultural events.

The Foundation was established in 2007 with the aim of facilitating the development of Russia’s economic potential, promoting its national interests, and strengthening the country’s image. One of the roles of the Foundation is to comprehensively evaluate, analyse, and cover issues on the Russian and global economic agendas. It also offers administrative services, provides promotional support for business projects and attracting investment, and helps foster social entrepreneurship and charitable initiatives.

Each year, the Foundation’s events draw participants from 208 countries and territories, with more than 15,000 media representatives working on-site at Roscongress’ various venues. The Foundation benefits from analytical and professional expertise provided by 5000 people working in Russia and abroad. In addition, it works in close cooperation with 131 economic partners; industrialists’ and entrepreneurs’ unions; and financial, trade, and business associations from 70 countries worldwide.

RC personal account
Восстановление пароля
Введите адрес электронной почты или телефон, указанные при регистрации. Вам будет отправлена инструкция по восстановлению пароля.
Некорректный формат электронной почты или телефона
Irina  Panarina

Irina Panarina

General Manager, Russia and Eurasia, AstraZeneca
Quotes
07.06.2019
SPIEF 2019
A Recipe for Global Competitiveness for Russian Industry
There are two opportunities: the first one is exports, and the other one is developing domestic innovations
07.06.2019
SPIEF 2019
Russia–Sweden
During the past two years we transferred technology for some of our most high-tech medications. We are to do more than just produce. The development of science in Russia matters for our company. We support start-ups and biopharmaceutical clusters
06.06.2019
SPIEF 2019
A Substantive Dialogue Between Global Pharmaceutical Players and BRICS Economies on the Rules of Fair and Equitable Competition
Yes, there is a place for compulsory licensing, but the criteria should be clearly defined, understandable, and not applicable in such a wide range as instances as is being discussed currently
13.02.2019
Healthy Life Forum: Towards 80+ 2019
A System of Universal Medicine Provision: Key to Achieving the National Goal
Risk-sharing agreements definitely exist, there are about 500 of them, and they are particularly popular in certain countries. In some countries, before expensive, innovative medicines are covered, an agreement lasting 4 to 5 years is signed, and the government evaluates the result. If there is an excess of funds spent on this medicine, the company must reimburse this excess
13.02.2019
Healthy Life Forum: Towards 80+ 2019
The Digitalization of Healthcare: Investing to Save Lives
We bet on three things: telemedicine, Internet of Things and patient registries
26.05.2018
SPIEF 2018
Providing Medications to the Russian Population
The social component is very important in our sector, and as responsible companies, we are obliged to not simply write it off
24.05.2018
SPIEF 2018
Breakthrough Technologies in Medicine: Evolution, Revolution, Organization
With the use of big data and mathematical modelling, it is possible to predict the endpoints of the study, for example, combinations in the field of oncology
24.05.2018
SPIEF 2018
Pitch Session for Startups: New Areas of Growth for Business and Government
The key is the PPP mechanism, so that telemedicine is not just a pilot project, but gets integrated into the health system for the benefit of patients